Trial
NCT00178854
Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
Janssen, LP
Condition
Treatment Resistant Depression
Intervention
Risperidone
Why stopped
failed recruitment efforts
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-04